ANAB vs BOLD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANAB Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AnaptysBio, Inc. Common Stock (ANAB) driven by superior Valuation, Growth & Margin while BOLD counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, ANAB trades at 35.7x Forward P/E with 15.0% operating margin (-60.3% YoY revenue) versus BOLD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ANAB sits in BREAKDOWN (18th %ile IV; Dealer Gamma Walls on Pro) against BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ANAB | BOLD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.4B | $56.2M | Larger Scale | ANAB |
| Trailing P/E Ratio Valuation | 7.3x | N/M | Lower Multiple | ANAB |
| Forward P/E Ratio Valuation | 35.7x | N/M | Lower Multiple | ANAB |
| Revenue Growth (YoY) Growth | -60.3% | +0.0% | Higher Growth | BOLD |
| Operating Margin (TTM) Profitability | 15.0% | 0.0% | Higher Margin | ANAB |
| Net Profit Margin Profitability | 417.6% | 0.0% | Higher Margin | ANAB |
| Return on Equity (ROE) Capital Efficiency | -114.5% | -64.6% | Higher ROE | BOLD |
| 52-Week Range Position Momentum | 34% ($33โ$73) | 62% ($1โ$3) | Stronger Trend | BOLD |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 34% Vol | -0.08ฮฒ ยท 28% Vol | Lower Realized Risk | BOLD |
| Unified Institutional Score Composite Signal | 54.8 / 100 (HOLD) | 36.8 / 100 (SELL) | Higher Composite | ANAB |